KEYNOTE-942 mRNA-Based vaccine and novel techniques in the field of melanoma - report from ESMO2023

from Medical Digest & Congress Report · host Medical Congress News

Professor Jeffrey Weber shares his thoughts on the novel techniques in the field of melanoma. Like 5-Year Efficacy and Biomarker Results from CheckMate 238 and KEYNOTE-942, a combination of pembrolizumab plus a novel mRNA-based vaccine based on personalised neoantigens from patients with high-risk resected melanoma. Video: https://medicaldigest.org/scientific-contents/interview:keynote-942-mrna-based-vaccine-and-novel-techniques-field-melanoma

Episode metadata supplied by the publisher feed · Published Nov 3, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

KEYNOTE-942 mRNA-Based vaccine and novel techniques in the field of melanoma - report from ESMO2023

0:00 7:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 7 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 3, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!